Brief: Sanofi Q1 Business Operating Income Beats Vara Consensus
23/04/2026 06:42
April 23 (Reuters) - Sanofi SA SASY.PA: CONFIRMED 2026 GUIDANCE Q1 FCF EUR 1.05 BILLION Q1 BUSINESS OPERATING INCOME EUR 2.97 BILLION VERSUS EUR 2.85 BILLION SEEN IN VARA CONSENSUS Q1 BUSINESS EPS EUR 1.88 VERSUS EUR 1.78 SEEN IN VARA CONSENSUS Q1 BUSINESS NET INCOME EUR 2.26 BILLION VERSUS EUR 2.16 BILLION SEEN IN VARA CONSENSUS Q1 NET SALES EUR 10.51 BILLION VERSUS EUR 10.22 BILLION SEEN IN VARA CONSENSUS Source text: ID:nGNX3mXBmH Further company coverage: SASY.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sanofi SA
See all newsFDA approves expanded use of Sanofi's type 1 diabetes drug (updated)
Brief: FDA Approves Tzield For Pediatric Stage 3 Type I Diabetes
FDA approves Sanofi's drug for stage 3 type 1 diabetes in children
European shares steady as investors weigh US-Iran flare-up (updated)
European shares steady as investors cling to Mideast peace hopes